HANALL BIOPHARMA CO., LTD.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 20235
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 788
 
  
 
C07K PEPTIDES 7129
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 4163
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 4202
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 2136
 
  
 
C07D HETEROCYCLIC COMPOUNDS 2160
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
  
 
G06F ELECTRIC DIGITAL DATA PROCESSING 1446

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9655916 Compositions for external application, containing adenosylcobalamin for improvement of skin diseasesJan 20, 15May 23, 17[A61K]
9580490 Uses of modified human tumor necrosis factor receptor-1 polypeptideFeb 07, 13Feb 28, 17[A61K, C07K]
9068019 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing sameOct 19, 10Jun 30, 15[A61K, C12N, C07K]
8895500 Modified human tumor necrosis factor receptor-I polypeptide or fragment thereof, and method for preparing sameSep 07, 11Nov 25, 14[A61K, C12N, C07K]
8754037 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing sameDec 21, 11Jun 17, 14[A61K, C07H, C12N, A61P, C07K]
8722674 1,3,5-triazine-2,4,6-triamine compound or pharmaceutical acceptable salt thereof, and pharmaceutical composition comprising the sameAug 28, 08May 13, 14[A61K, C07D]
8642083 Controlled release complex composition comprising angiotensin-II-receptor blockers and HMG-CoA reductase inhibitorsOct 30, 07Feb 04, 14[A61K]
8541474 N,N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the sameSep 23, 11Sep 24, 13[A61K, A01N, C07C]
8394845 Method of using combination preparation comprising angiotensin-II-receptor blocker and HMG-CoA reductase inhibitorMay 11, 11Mar 12, 13[A01N]
8252743 Modified erythropoietin polypeptides and uses thereof for treatmentNov 28, 07Aug 28, 12[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0377,346 BOSENTAN CONTROLLED RELEASE ORAL PREPARATIONAbandonedMay 10, 13Dec 25, 14[A61K]
2014/0235,558 PHARMACEUTICAL COMPOSITION HAVING ACTIVITY OF ANTICANCERAbandonedJun 28, 13Aug 21, 14[A61K]
2014/0235,559 ANTI-CANCER PHARMACEUTICAL COMPOSITIONAbandonedJun 15, 11Aug 21, 14[A61K]
8648111 N1-2-thiophene-2-ylethyl-N2-substituted biguanide derivate, preparation method thereof, and pharmaceutical composition containing the same as active ingredientsExpiredOct 13, 09Feb 11, 14[A61K, C07D]
8642647 N1-benzo[1,3]dioxol-5-ylmethyl-N2-substituted biguanide derivative, preparation method thereof, and pharmaceutical composition containing sameExpiredOct 13, 09Feb 04, 14[A61K, C07D]
8618045 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing sameWithdrawnDec 21, 11Dec 31, 13[A61K, C07H, C12N, A61P, C07K]
2013/0158,084 Pharmaceutical Composition Comprising Losartin For Treating or Preventing Statin BasedGrug-Induced Muscle ToxicityAbandonedMar 28, 12Jun 20, 13[A61K, C07D, A61P]
2013/0084,329 COMPOSITIONS FOR EXTERNAL APPLICATION, CONTAINING ADENOSYLCOBALAMIN FOR IMPROVEMENT OF SKIN DISEASESAbandonedNov 16, 12Apr 04, 13[A61K]
2013/0071,471 PHARMACEUTICAL COMPOSITION FOR TREATING ATOPIC DERMATITISAbandonedNov 16, 12Mar 21, 13[A61K]
2012/0264,686 MODIFIED ERYTHROPOIETIN (EPO) POLYPEPTIDES THAT EXHIBIT INCREASED PROTEASE RESISTANCE AND PHARMACEUTICAL COMPOSITIONS THEREOFAbandonedMay 29, 09Oct 18, 12[A61K, C12N, A61P, C07K]
2012/0135,952 BUTYRIC ACID SALT OF N,N-DIMETHYL IMIDOCARBON IMIDIC DIAMIDE, METHOD OF PREPARING SAME, AND PHARMACEUTICAL COMPOSITIONS AND COMBINATIONS CONTAINING SAMEAbandonedJul 16, 10May 31, 12[A61K, C07C, A61P]
2012/0015,032 COMBINATION PREPARATION COMPRISING INHIBITOR OF HMG-COA REDUCTASE AND ASPIRIN AND METHOD FOR MANUFACTURING THE SAMEAbandonedAug 08, 08Jan 19, 12[A61K, A61P]
2011/0294,733 MODIFIED HUMAN THROMBOPOIETIN POLYPEPTIDE FRAGMENT AND MANUFACTURING METHOD THEREOFAbandonedJan 20, 10Dec 01, 11[A61K, C07H, C12N, A61P, C07K]
8057787 Protease resistant modified interferon-beta polypeptidesExpiredApr 09, 08Nov 15, 11[A61K]
8052964 Interferon-β mutants with increased anti-proliferative activityExpiredApr 09, 08Nov 08, 11[A61K, A01N, C07K]
2011/0212,175 COMBINATION PREPARATION COMPRISING ANGIOTENSIN-II-RECEPTOR BLOCKER AND HMG-COA REDUCTASE INHIBITORAbandonedMay 11, 11Sep 01, 11[A61K, A61P]
2011/0135,714 COMPOSITIONS FOR EXTERNAL APPLICATION, CONTAINING ADENOSYL COBALAMIN FOR IMPROVEMENT OF SKIN DISEASESAbandonedJan 28, 11Jun 09, 11[A61K, A61P]
2011/0123,612 PHARMACEUTICAL PREPARATION CONTAINING NON-DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-2 RECEPTOR BLOCKERAbandonedApr 03, 09May 26, 11[A61K, A61P]
2011/0117,194 PHARMACEUTICAL FORMULATION CONTAINING ANGIOTENSIN-II RECEPTOR BLOCKERAbandonedApr 28, 09May 19, 11[A61K, A61P]
2011/0111,021 PHARMACEUTICAL PREPARATIONAbandonedFeb 23, 09May 12, 11[A61K, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.